2014 長 庚 紀 念 醫 院 微 創 胸 腔 手 術 國 際 研 討 會December 13, 2014, 林口長庚紀念醫院 復健大樓第一會議廳

Time Topic Speaker Moderator07:30~8:20 Registration

08:20~8:30 Opening Hui-Ping LiuYun-Hen Liu

Jun WangLiang-Shun Wang

Session 1: 胸腔手術進展(Advance in Thoracic Surgery )

08:30~10:00

Current status in Lung transplantation  Yoshiya ToyodaChung-Ping HsuJang-Ming LeeYi-Cheng Wu

Technical consideration in VATS lobectomy Jun Wang

Trouble shooting in complicated VATS esophagectomy

Hiroyuki Daiko

Trick and Treat in VATS Hui-Ping Liu

Discussion

10:00~10:30 BREAK

Session 2: 機器手臂胸腔手術 (Robotic thoracic surgery)

10:30~12:00

Recent advances in robotic surgery in esophageal cancer

Dae Joon Kim

Han-Shui HsuYao FongWu-Wei Lai

Robotic surgery of the lung in Taiwan Jang-Ming Lee

Robotic surgery of the esophagus in Taiwan Chih-Cheng Hsieh

Robotic surgery of the mediastinum in Taiwan Ying-Chieh Su

Robotic training and resident education in thoracic surgery

Ming-Ju Hsieh

Discussion

12:00~12:30 Lunch symposium Cheng-Yen ChuangYu-Jen ChengJiun-Yi HsiaMing-Shian Lu

Session 3: 單一傷口胸腔鏡手術 (Single Port VATS)

12:30~14:00

Recent Advances in uniport surgeryGonzalez Rivas Diego

Hung ChangChin-Yuan ChengHung-I Lu

Nonintubated Uniport thoracoscopic surgery Jin-Shing Chen

Uniport video-assisted thoracoscopic surgery Chia-Chuan Liu

Uniport subxyphoid approach in thoracic surgery Wei-Cheng Lin

Uniport surgery in thoracic disease using flexible videoscopy

Tzu-Ping Chen

Discussion

14:00~14:30 BREAK

Session 4: 自然孔腔胸腔手術 (NOS in thoracic surgery)14:30~16:00 POEM in Japan Hironari Shiwaku  Shah-Hwa Chou

Hsin-Yuan FangPOEM in China Ping-Hong Zhou

Yu-Chung Wu

ENB in thoracic disease Hao Wang

Transumbilical thoracic surgery in human Wei-Sheng Chen

Transumbilical thoracic surgery in lab Yun-Hen Liu

16:00~16:30 BREAK

Session 5: 其他 (Miscellaneous)

16:30~17:30

Database management in lung cancer Sanghoon JheonYih-Gang GoanWen-Chieh Huang Ching Tzao

Database management in esophageal cancer Yin-Kai Chao

The new frontiers in minimally invasive thoracic surgery

Anthony PC Yim

Discussion

Building Successful Lung Transplantation Programs – Role of Minimally Invasive Antero-Axillary Approach

Temple University School of Medicine, Philadelphia, PA, USA

Yoshiya Toyoda

I have had the privilege to work as the surgical director in lung transplantation with my talented, hard-working colleagues at both a large and a small center in the US over the past decade. We were successful in transforming an already large center to the largest center in the world, and an inactivated, small center to one of the largest centers with one of the best outcomes in the US. We have seen an inherent risk in increasing volume as possible poor outcomes due to the acceptance of high risk recipients and donors. At my former center, our lung transplant volume increased from 58 in 2004, to 87 in 2005 and 93 in 2006. However, the 1-year graft survival decreased from 87% to 76%. Afterwards, we were able to improve it to 88% while further increasing volume (Figure 1). To improve outcomes, we developed a less invasive approach to perform lung transplantation. We named it as “antero-axillary approach.” Our standard approach for single lung transplantation changed from postero-lateral approach to antero-axillary approach and for double lung transplantation from clamshell approach to antero-axillary approach. These lessons helped in the building of my current program. Our Temple lung transplant program was inactivated in 2011 due to poor outcomes and low volume. Since then, the program was re-activated in 2012, and our annual lung transplant volume increased from 7 to 21 to 44 (Figure 2). The number of our active patients on the wait-list increased from 13 to 37 from 2012 to 2013. We have extended the recipient selection criteria. In 2013, 48.1% of our recipients were age 65 years and older, and 14.8% were with a body mass index higher than 31. While increasing volume, we were able to improve our outcomes as well (Figure3). I would like to share my experiences with our colleague in Taiwan.

Thoracosopic Esophagectomy in the Prone Position including Trouble Shooting.

National Cancer Center Hospital East, Chiba, Japan

HIROYUKI DAIKO

Despite the recent advance in thoracoscopic techniques for carcinoma of the esophagus, transthoracic esophagectomy is still standard operative approach in Japan. In my institution, thoracoscopic esophagectomy in the prone position (TSEP) was started from 2008 only for clinical stage I carcinoma of the esophagus at that time. However, TSEP has been gradually adapted to more advanced disease. Latest indication of TSEP is clinical T1-3 excluding patients with failure after definitive chemoradiotherapy at the present time. More than 300 patients with carcinoma of the esophagus were underwent TSEP, three of them were converted to open approach because of the intraoperative trouble caused by energy device. Recently, magnifying observation using endscopy is more focused on thoracoscopic surgery for carcinoma of the esophagus. There is no patient who is converted to open approach from 2012, when TSEP can be performed with magnifying observation. Thoracoscopic esophagectomy based on the magnifying observation has advantages for the safety, curability and excellent QOL.

Recent Advances In Robotic Surgery In Esophageal Cancer

Severance HospitalYonsei University College of MedicineSeoul, Korea

Dae Joon Kim

Since the first successful robotic esophagectomy was reported in 2004, there have been several case reports from US, Europe, and Asia. We can observe some differences in their approaches and technical details between Western countries and East Asia. This is mainly due to the differences in tumor histology, body habitus, incidence of GERD, and a strategy of lymph node dissection. Although we expect the better early outcome in robotic esophagectomy series, there has been no evidence to prove this. In 2012, a randomized controlled trial which compares the outcome of robotic esophagectomy and open esophagectomy (ROBOT trial) has been started, and we hope that this trial will tell us the answer. From technical point of view, there have been a gradual improvement of da Vinci system (Intuitive Surgical, US) from da Vinci (with 3 arms) to da Vinci Si over a decade. We have seen the improvement of imaging quality, maneuverability as well as the education environment because of an assistant console. In my experience, robotic surgery for esophageal cancer can offer the following advantages as compared to VATS esophagectomy ; (1) learning the procedure is faster, (2) dissection of the upper mediastinum is easier, (3) no experts are required for assistance, (4) teaching our trainees is more efficient. However, there are some issues that should be addressed. Firstly, recent series from Korea and Japan failed to demonstrate a significant decrease in the incidence of vocal cord palsy. Second, considering that no studies could prove the shorter hospital stay, one can argue its higher installation and maintenance costs. NIR-image guided surgery and a newer platform may solve these problems. As mechanical engineering and information technology evolve, it is very difficult to expect that we will continue esophagectomy under current VATS system in 10-20 years later. I think we are experiencing a paradigm shift from traditional endoscopic surgery to a certain type of future surgery. It is a duty of our generation to develop a better technique with newer system and to educate our trainees.

Robot-assisted Thoracic Surgery

Jang-Ming Lee MD

Departments of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, 7 Chung-San South Road, Taipei 100, Taiwan

Minimally invasive surgery using thoracoscopy have been gradually adopted to be an effective surgical approaches to treat various thoracic disease. However, 2D-imaging system and limitation in instrument manipulation through a small port has long been criticized by some surgeons. With the novel robotic surgical system using 3-D high definition imaging and 7-degree of freedom for instrumentation, many thoracic surgical procedures have been reported to been safely and effective performed, including lobectomy, thymothymectomy and esophagectomy. From February 2012 to Oct 2014 . We performed 123 cases of robotic-assisted thoracic surgery including thymothymectomy (10), lobectomy or segmentectomy (99), esophagectomy or excision of esophageal tumor (14). We found it was especially useful for the lesion with difficult approach or requiring complex procedure such as bronchoplasty. From our limited experience, robot-assisted thoracic surgery is feasible and safe and can provide the patients of thoracic disease with difficult approach or requiring complex procedure the chance to be treated with minimally invasive surgery. However, it role in thoracic surgery especially for the long term treatment outcome required to be examined in the future.

Robotic surgery of the esophagus—the Experience of Taipei Veterans General Hospital

Chih-Cheng Hsieh, M.D.

Division of Thoracic Surgery, Department of Surgery, Taipei-Veterans General Hospita

From Nov. 2010, there were 30 patients received robotic surgery for esophageal diseases in Taipei-Veterans General Hospital. Except 2 patients with achalasia, the other (28/30) patients had esophageal cancer. All patients were male and the mean age was 58.9 years, ranging from 47 to 84 years. The tumors in most patients were near the carina level and 11 patients received pre-operative concurrent chemoradiotherapy. There were 3 patients received robotic gastric tube preparation and 5 laparoscopic preparation. The average console time in thoracic phase was about 2.5 hours and blood loss was 226ml. Post-operative lengths of stay were 18.7 days. There was 1 case converted to minithoracotomy due to huge tumor. One patient had azygos vein injury with bleeding and repaired using robotic instruments. There were several post-operative complications, included hoarseness, chylothorax, neck lymph leakage, anastomosis leakage, prolonged ventilator use and gastroparalysis. In our initial experience of robotic surgery for esophagectomy, the convert rate and hospital stay were not higher than those of VATS at least. Robotic assisted thoracoscopic surgery is feasible and worth to evolve continuously.

Robotic surgery of the mediastinum in Taiwan.

Ying-Chieh Su, M.D.

Department of thoracic surgery, Chimei medical center

AbstractRATS (Robot assisted thoracoscopic surgery) had a burst progress in Taiwan since 2012. Over 400 RATS were practiced in Taiwan. Among them, 37 cases were mediastinal tumor surgery. In Chimei medical center, we performed 16 cases of RATS mediastinal surgery. Half of them were extended thymothymectomy. High degree of freedom of the da Vinci robot instrument made it widely used in surgery in small space like pelvis. The same situation happened in mediastinal surgery. With our surgical experiences, we found da Vinci robot made extended thymothymectomy more practical. It’s technically easy and safe. And we feel more confident about the cleanliness thymothymectomy.We’d like to show some short term outcomes and technical details in robotic surgery of the mediastinum.

Expandable stents for esophageal lesion

Cheng-Yen Chuang, MD.

Division of Thoracic Surgery, Surgical department, Taichung Veterans General Hospital

Expandable metal stents are very often used for esophageal lesions, especially in esophageal cancer patients who cannot receive surgical intervention. Other indications include esophageal stricture caused by intrinsic and/or extrinsic malignant tumor compression, or esophageal fistula. The long term usage of metal stent in benign lesion is contraindicated. In such situation, hybrid stent (mix silicone and metal) is more suitable. Before placing stents, identifying the esophageal lesions and choose correct stents are very improtant. Covered stent ? Non-covered stent ? Proximal release ? Distal release ? are key points in selection of proper stents. The placement of an esophageal stent has several steps: Visualizing, Measuring, Marking, and Deployment. After stent placement, adequate follow-up and instructions for oral intake are mandatory. There several potential complications for stents placement: perforation; stent migration; tumor over growth at the end of the stent or in-growth through the stent; food impaction; tracheal compression; and pain. Proper management will increase the satisfaction and promote the quality of life of patients.

RECENT ADVANCES IN UNIPORTAL VATS SURGERY

Diego Gonzalez-Rivas, MD, FECTS

Thanks to the recent improvements in thoracoscopy, a great deal of complex lung resections can be performed without performing thoracotomies. During the last years, experience gained through video-assisted thoracoscopic techniques ,enhancement of the surgical instruments and improvement of high definition cameras have been the greatest advances. The huge number of surgical videos posting on specialized websites, live surgery events and experimental courses has contributed to the rapid learning of minimally invasive surgery during the last years. Nowadays, complex resections are being performed by thoracoscopic approach in experienced centers. Additionally, surgery has evolved regarding the thoracoscopic surgical approach, allowing us to perform difficult procedures by means of a small single incision, with excellent postoperative results. Uniportal video-assisted thoracic surgery (VATS) has a history spanning over more than 10 years and, more recently, has become an increasingly popular approach to manage most of the thoracic surgical diseases. The potential advantages of reduced access trauma and better cosmesis, together with patient demand, have seen uniportal VATS spread across the world. Since we developed the uniportal technique for VATS major pulmonary resections in 2010 we have increased the application of this technique to more than 95% of cases in our routine surgical practice. The experience we acquired with the single port technique during the last years, as well as technological improvements in high definition cameras, development of new instruments, vascular clips and more angulated staplers have made this approach safer, incrementing the indications for single-port thoracoscopic resections. We believe it is important to minimize the surgical aggressiveness especially in advanced stage lung cancer patients where the immune system is weakened by the disease or by induction treatments. The minimally invasive surgery represents the least aggressive form to operate lung cancer and the single-port or uniportal technique is the final evolution in these minimally invasive surgical techniques. The future of the thoracic surgery is based on evolution of surgical procedures and innovations to try to reduce even more the surgical and anesthetic trauma. We truly believe on the use of the single port technique combined with future robotic technology for major pulmonary resections because we understand that the future goes in the direction of digital technology which improve the adoption of single port technique worldwide in the next coming years.The current DaVinci robotic technology has been around for over a decade. Despite offering excellent visual feedback and robotic arm dexterity and precision, several ports are still required for the lobectomy. Although performing robotic surgery throughspecialized single-incision laparoscopic surgery (SILS) ports is possible with computer-compensated movements to overcome the difficulties associated with instrument crossover, robotic SILS is probably the limit for the current system design in terms of minimizing surgical access trauma. The main reason for this limitation is simple; essentially the robot is ‘outside’ of the patient. To move forwards into a higher realm, the whole robotic approach needs to be revised. To perform complex robotic thoracic surgery through a single small incision, the robot’s ‘shoulders’, ‘arms’ and ‘head and eyes’ must move inside the thoracic cavity with parallel instrumentations, making the procedure more anatomic and easy.

Recent innovations in single port approach are the use of subxyphoid technique and the thoracoscopic lobectomy in non intubated patients. Liu et al from Taiwan successfully performed the first cases of uniportal VATS lobectomies via a subxyphoid approach, which might reduce the risk of intercostal nerve injury and avoids the limitations imposed by narrow rib spaces. One of the limitations of this approach are the transmitted pulsation from the heart to

the VATS instruments and the difficulties to control a bleeding from upper lobe tumors. Interestingly, an additional advantage of the subxyphoid approach is the ability to gain access to bilateral thoracic cavities to perform bilateral lung resections through a single incisionWe expect further development of new technologies like sealing devices for all vessels and fissure, robotic arms that open inside the thorax and wireless cameras, which will probably allow the uniportal approach to become the standard surgical procedure for major pulmonary resections in most thoracic departments. We recently introduced in our department the uniportal VATS lobectomy tecnnique in non intubated patients. The combination of nonintubated or awake thoracoscopic surgery and single-port VATS technique is promising because it represents the least invasive procedure for pulmonary resections. Thanks to avoidance of intubation, mechanical ventilation and muscle relaxants the anesthetic side effects are minimal allowing to most of the patients to be included in a fast protocol avoiding the stay in a intensive care unit. Given that only one intercostal space is opened, the use of local anesthesia and blockade of a single intercostal space is enough for pain control at the beginning and during the surgery (no epidural and no vagus blockade is necessary in the single port approach). We use no trocar and during instrumentation we try to avoid pressure on the intercostal nerve so we reduce the risk of intercostal bundle injury. This non intubated major pulmonary resctions must only be performed by experienced anesthesiologists and uniportal thoracoscopic surgeons (preferably skilled and experienced with complex or advanced cases and bleeding control through VATS).

Nonintubated Uniportal Thoracoscopic Surgery

Jin-Shing Chen, MD, PhD

Professor, Department of Surgery, National Taiwan University, Taipei, TaiwanDirector, Department of Traumatology, National Taiwan University Hospital and National Taiwan University

College of Medicine, Taipei, Taiwan

AbstractBackground. Uniportal video-assisted thoracoscopic surgery (VATS) is recently introduced for various thoracic diseases. However, management of peripheral lung nodules by uniportal VATS, without tracheal intubation, has rarely been attempted. We evaluated the feasibility and safety of nonintubated uniportal VATS for peripheral lung nodules.Methods. From January 2014 to October 2014, 110 patients with indeterminate peripheral lung nodules underwent uniportal VATS with or without tracheal intubation. Computed tomography-guided dye-localization was used to identify small or ground-glass opacity lesions.Results. A definite diagnosis was obtained in all patients, of whom wedge resection was performed in 103, segmentectomy in 5 and lobectomy in 2. Conversion to conventional 3-port VATS was required in 6 patients because of primary lung cancer requiring further resection for adequacy of margins or difficulty in identifying the small nodule. One patient required conversion to intubated one-lung ventilation because of vigorous mediastinal movement. Operative complications developed in 4 patients who had an air leak for more than 3 days postoperatively. The mean duration of postoperative chest tube drainage and mean hospital stay were 1.5 days and 3.0 days, respectively. Conclusions. Nonintubated uniportal VATS are technically feasible and as safe as intubated uniportal VATS to provide selected patients a less invasive alternative in managing their indeterminate peripheral lung nodules.

Uniport video-assisted thoracoscopic surgery

Chia-Chuan, Liu MD

Sun Yat-Sen Cancer Center, Taiwan.

LESS plays a very important role in recent development of minimally invasive surgery. From reduced ports to single port surgery, rapid progression on design of surgical devices has been noted, e.g. 3-D camera system, 5mm endostapler, articulate instruments, and these newly designed devices allow we surgeons more rooms to perform more advance and delicate operations. From simple wedge resection to anatomic lung resection, lymph node dissection, even sleeve resection, and troubleshooting - as management of pulmonary artery bleeding, tumor after chemoradiation; single port VATS, just like other multi-port VATS, has documented its feasibility and safety by many reports, and more importantly, training program has been setup in some experienced centers. What have we achieved from multiple port VATS to uniport VATS? We still lack of strong evidence on periopearative outcome and pain study, and it is lessly like we are going to have survival advantage just by reducing the number of port, however; we did reduced trauma to the patient and also regain the traditional baseball field setting for endoscopic surgery, with camera in the center; and this is usually compromised during multi-ports VATS - when camera was inserted on the mid or even posterior axillary at different lower intercostal space. In addition to reduced trauma outside on the wound, several directions on single port surgery are aimed to further reduce trauma to the patient, non-intubated single port surgery, aimed on reducing anesthesia induced trauma; sub-lobar resection (segmentectomies /segmentectomy /subsegmentectomy) to preserve more lung parenchyma, and sub-xiphoid single port surgery aimed on reducing post-operative neuralgia; also single port robotic system also available now, and definitely will going to have rapid progression in some fields, thoracic surgery included. We are looking forwardly to have more new ideas and data in the future in this era to bring more benefits to our patients.

Uniport subxyphoid approach in thoracic surgery

Wei-Cheng Lin, M.D.

Division of Thoracic Surgery, Department of Surgery, Wang Fong Hospital

Although conventional Video-Assisted Thoracoscopic Surgery (VATS) has been shown to provide better post-operative recovery, in comparison to thoacotomy, there are still some disadvantages about this approach, such as intercostal neuropathy. To overcome these disadvantages, we developed a novel subxyphoid approach, which utilized single-port VATS technique, to accomplish a range of different thoracic surgical procedures. By adopting this subxyphoid approach, we could perform operations in bilateral pleural cavity and peritoneal cavity simultaneously via only one non-rib cage entry. Due to avoidance of injury at intercostal space, patients might be free from both acute and chronic neuropathy. For primary spontaneous pneumothorax, 12 patients underwent this subxyphoid single-port VATS from January to October 2014. The mean Visual Analogue Scale (VAS) for pain in those patients on post-operative day (POD) one was 1.00 ± 0.49. Those patient suffered significantly less pain than patients, who underwent conventional single-port VATS in our hospital (n=45, mean VAS on POD 1=1.92 ± 1.01, p＜0.001).However, we inevitably encountered some disadvantages for this approach. Apex and posterior mediastnum were difficult to be reached by conventional VATS instruments. Transient arrhythmia caused by compression of heart by instruments and endoscope during operation in left pleural cavity occurred occasionallyHerein, we presented our preliminary experience of subxyphoid single-port VATS and the potential advantages about this approach.

Uniport surgery in thoracic disease using flexible videoscopyTzu-Ping Chen, Chi-Hsiao Yeh, Yen-Hun LiuDepartment of Thoracic and Cardiovascular Surgery, Chang Gung Memorial Hospital at Keelung`

Background:Uniport thoracscopic surgery is a very exciting new modality in the field of minimal access surgery which works for further reducing the scars of traditional three-port thoracopic surgery and towards scarless surgery. By using the rigid videoscope, single-incision seems to offer an advantage to surgeons with its familiar field of view similar to those used in conventional thoracotomy. However, the disadvantage is the fencing from individual instruments placed through the small incision of single-port VATS. rapid progress in instrument design. We describe herein our technique of performing uniport thoracoscopic surgery using a flexible scopeMaterials and Methods:Between August 2013 and July 2014, 62 uniportal VATS procedures were performed by a single surgeon. Of the 62 uniportal VATS, 6 lobectomies were performed for early stage lung cancer. All procedures were complete with a 10-mm 0-degree rigid endoscope through a plastic wound protector(Alexis®). A 5-mm flexible-tip video endoscope (HD EndoEYE LTF-VH™; Olympus) was applied during pneumonolysis and mediastinal lymph node dissection. Vessels were stapled under loverlooking of flexible videoscope, as well as the lobar bronchus. Results:No post-operative complication or hospital mortality of uniportal VATS lobectomy was recorded. No patients was converted to open thoracotomy or created additional skin incisions. Mean operative time of uniportal VATS lobectomy was 165.6 min (range 110-270) and mean postoperative hospital stay 8.5 days (range 7-12). Conclusion:Our experience shows that VATS combines with a flexible scope is feasible in lobectomy, even in some cases of pleural adhesion. Despite the longer time to perform unport VATS, we consider the combined rigid and flexible videoscope to achieve better vision and safer maneuver during the operation. We also expect further development of new ergonomic instruments, robotic arms that open inside the thorax, which may allow the uniportal approach to become a mainstreams of the major pulmonary resections in most thoracic departments.

POEM in Japan Hironari Shiwaku1), Haruhiro Inoue2)

 

Department of Gastroenterological Surgery,  Fukuoka University Faculty of Medicine1)

Digestive Disease Center,  Showa University Koto Toyosu Hospital 2)

 

【Abstract 】Achalasia, a rare functional motility disorder of the esophagus, is characterized by incomplete lower esophageal sphincter (LES) relaxation, increased LES tone, and aperistalsis of the esophagus. Clinical symptoms of achalasia include dysphagia, regurgitation, and chest pain. Peroral endoscopic myotomy (POEM) is a revolutionary therapy for achalasia that was reported in 2008 by Inoue and colleagues. POEM is less invasive and has a higher curative effect compared with conventional therapeutic methods; therefore it is expected to become the standard treatment for achalasia and related disorders worldwide, in the near future. Based on our experience of 850 cases in Japan, we would like to introduce the technique of POEM procedure and current situation. 

POEM in China

Prof. Pinghong Zhou, M.D, Ph.D

Endoscopy Center, Zhongshan Hospital, Fudan University, Shanghai, 200032, China

Peroral endoscopic myotomy (POEM) has been developed as a non-incision, minimally invasive endoscopic treatment becoming the most effective option for achalasia, maybe the primary and permanent one. This procedure incorporates concepts of natural orifice transluminal endoscopic surgery (NOTES) and achieves endoscopic myotomy by using the submucosal tunnel as an operating space. In 2007, Pascricha et al. used this technique firstly and successfully to perform endoscopic myotomy in a porcine model. Later, Inoue et al. made it successful in human patients and got a satisfactory outcome. Then, POEM has been developed very quickly and initial published experience in humans is more than encouraging despite a relatively short follow-up. In China, the first case of POEM was performed in the Endoscopy Center of Zhongshan Hospital, Shanghai in August 2010. To date POEM procedures have been performed in over 2000 patients in China, which may be over half the total cases of the world. China also established its consensus on POEM from academic society in 2012. Initial experiences from China about management of the complications and POEM for special cases (such as pediatric patients and patients with sigmoid-type esophagus or recurrent symptoms after Heller myotomy) have been reported in several international conferences many times. As Chinese doctors become more experienced, they also make some modifications for achieving long-term symptom remission and reducing the difficulty of POEM. These modifications include water-jet assisted, posterior wall incision, full-thickness myotomy, and a “push-and-pull” technique for myotomy, etc. The mean POEM procedure time was just 35 minutes in our unit, and the age of patients with POEM ranged from 2 to 98 years.The emerging of POEM marked the rising of a new branch of therapeutic endoscopy—— tunnel endoscopic surgery (TES), which includes several novel procedures utilizing a submucosal tunnel as an operating space. In 2010, we innovated a new method by tunneling technique for treating upper gastrointestinal (GI) submucosal tumors (SMTs) originating from the muscularis propria layer and coined the acronym STER (submucosal tunneling endoscopic resection). Other applications of tunneling technique include peroral endoscopic submucosal pyloromyotomy for pyloric stenosis, endoscopic submucosal tunnel dissection for large esophageal neoplastic lesions, etc.

The development of tunnel endoscopic surgery is inspiring for both gastroenterologists and surgeons. The future of flexible endoscopy is not only operating in the natural orifice but also within and outside the gastrointestinal wall. If the lumen was historically the first and the peritoneal cavity the second, then the intramural space has come to represent the “third space.” GI endoscopy has finally entered the (third) space age!

ENB in thoracic disease

上海市肺科医院 汪浩摘要电磁导航支气管镜是通过胸部CT 模拟出虚拟支气管，定位外周病变并在磁场下实时进行导航的前沿技术，结合肺外周超声能对外周结节进行精确诊断及微创治疗。上海市肺科医院内镜科首次联合使用这两项技术诊疗肺外周病变，获得了良好的效果。本讲座主要通过介绍电磁导航支气管镜及肺外周超声的原理、设备、操作方法，复习国外相关文献，总结该院22例病例操作详情及结果，展示典型病例，进行分析，让大家对这一技术有全面的感性认识，也为进一步的推广与研究打下基础。

Transumbilical thoracic sympathectomy: a single center experience of 150 cases with up to 4 years of follow-up.

Weisheng Chen, M.D.

Department of Cardiothoracic Surgery, Fuzhou General Hospital, Fujian Medical University, Fuzhou, China.

Objective: Thoracic sympathectomy is considered as the most effective method to treat palmar hyperhidrosis. Here we report our experience of transumbilical thoracic sympathectomy with an ultrathin flexible endoscope for palmar hyperhidrosis in a series of 150 patients with up to 4 years of follow-up. Methods: A prospective database was used in this retrospective analysis of 150 patients (63 males, 87 females with mean age of 21.3 years) with palmar hyperhidrosis who were operated by the same surgeon in a single institution from April 2010 to March 2014. All procedures were performed under general anesthesia involving intubation with a double-lumen endotracheal tube. Demographic, postoperative, and long term data of patients were recorded and statistical analyses were performed. All patients were followed-up at least 6 months post procedure through clinic visits or telephone/e-mail interviews.Results: The procedure was performed successfully in 148 of the 150 patients. Two patients had to be converted to conventional thoracoscopic procedure because of severe pleural adhesions. Mean operating time was 43 (ranging from 39 to 107) min and the mean post-operative stay was one (range 1-4) days. All patients were interviewed 6–48 months after surgery and no diaphragmatic hernia and no Horner’s syndrome was observed. The rate of palmar hyperhidrosis and axillary hyperhidrosis resolution was 98% and 74%, respectively. Compensatory sweating was reported in 22.6% of patients. All of the patients were satisfied with the surgical results and the cosmetic outcome of the incision. Conclusions: This preliminary human experience suggests that transumbilical thoracic sympathectomy with the ultrathin flexible endoscope was a safe and efficacious alternative to the conventional approach. This technique avoided the chronic pain and chest wall paresthesia which associated with the chest incision. In addition, this novel procedure afforded maximum cosmetic benefits.

Transumbilical thoracic surgery in the lab

Yun-Hen Liu, M.D.

Department of Thoracic Surgery, Chang Gung Memorial Hospital

Since Kallo et al. reported the first transgastric peritoneoscopy in 2004, several studies have shown the safety and benefits of natural orifice surgery (NOS) in abdominal surgery in human studies. The feasibility of NOS thoracoscopy has been reported using different natural orifice access (transvesical, transesophageal, transtracheal, transoral, and transumbilical) in porcine and canine models. However, only a minority of thoracic procedures (myotomy for achalasia, sympathectomy for palmar hyperhidrosis) are performed using the NOS technique. We investigated the feasibility of transumbilical thoracoscopy in a canine model. We demonstrated thatpericardial window creation and large lung wedge resection could be performed via a 3 cm vertical transumbilical incision. More recently, we also found that anatomic lobectomy could be performed with the current approach but was associated with intraoperative complications. However, we strongly believe that increased familiarity with the surgical approach and refinement of endoscopic instruments might clarify the role of transumbilical surgery in thoracic disease.

Database management in Lung Cancer

Sanghoon Jheon, M.D., Ph.D.Professor and ChairmanDepartment of Thoracic and Cardiovascular SurgerySeoul National University College of Medicine, Seoul, Korea

The well-organized database for patients’ clinical information plays important role in medical research. Our institution has managed the lung cancer patients’ database based on Microsoft Access program since 2003. The database includes not only clinical information of the lung cancer patients but also information on tissue and blood samples that collected with informed consent. The database contains information the patients with primary lung cancer which includes low grade malignancy, recurred lung cancer and primary malignant disease of trachea. The exclusive manager is in charge of processing data and management of the database to maintain the quality of data.The basic structure of database consists of 4 categories and is composed of 13 data input sheets per one operation. The first 3 sheets are for clinical information on patient including previous medical history and data of laboratory, imaging examinations not only results of staging workup. The next part, made up with 5 input sheets, is designed to collect staging information of the tumor which includes both clinical and pathological staging data. Staging information is based upon TNM classification, using independent data columns for each TNM factors. The third part deals with information on whole treatment that the patient underwent. All information about neoadjuvant treatment, operation and adjuvant treatment are described in detail. The last part includes follow up data which is obtained outpatient basis. A nurse practitioner is in charge of update of this part upon each visits of the patient. A protocol with definition of each item is established to standardize management of the database. Also separately operated system is set up to manage patients lost to follow up.The tissue sample for the lung cancer tissue bank is taken at the operation room immediately after excision, prior to fixation. Both normal parenchymal tissue and tumor tissue are collected and stored in liquid nitrogen tank. Patient’s arterial blood sample is collected also via arterial line for the intraoperative monitoring and is also stored in the deep freezer. The record of the tissue and blood samples along with patient’s information is updated by means of both a printed document and an online-shared electronic document. The management system for tissue bank is prepared to search information of samples including associated consent forms, and to provide the most up-to-date status for each samples. Furthermore, information which is managed by the system can be accessed online. The well-managed database for clinical information and tissue bank are significant background for lung cancer research and improvement of the treatment for lung cancer.

Database management in esophageal cancer

Yin-Kai Chao MD , PhD

Department of thoracic surgery; Chang Gung memorial hospital, Taoyuan, Taiwan

Carcinoma of the esophagus is a highly malignant cancer and generally carries a poor prognosis. Most patients presented with advanced disease at initial diagnosis which prohibited any aggressive treatment. 5 yr survival is less than 25% even after complete surgical removal. In order to improve resectability and reduce distant metastases, the combination of chemotherapy, radiotherapy and surgery had been introduced since 1995. Recent one meta-analysis confirmed the benefit of increasing locoregional disease control after such strategy, especially in squamous cell carcinoma subtype.However, after the impact of CRT, accurate restaging of patients after resection is important because it provides prognostic information. Despite the advent of changes in the 7th American Joint Committee on Cancer (AJCC) staging system with the introduction of new parameters predicting outcomes (e.g., tumor differentiation, histological subtype, and tumor location), a reliable prognostic framework for ESCC patients undergoing nCRT is still lacking. Moreover, most data available to date have been obtained from primarily resected patients. In this scenario, the identification of potential prognostic markers in residual tumors after nCRT has recently gained momentum.In today's presentation, I will briefly describe CGMH experience in identifying the prognostic markers in neoadjuvantly treated esophageal cancer patients and our evolution from the "file"-based to "database"-based approach.

The New Frontiers in Minimally Invasive Thoracic Surgery

Anthony Ping-Chuen Yim, M.D.

Minimally Invasive Thoracic Surgery CentreThe Chinese University of Hong Kong

The past two decades have witnessed the adoption of video assisted thoracic surgery (VATS) to become the new standard of care in the surgical management of a wide spectrum of thoracic diseases. It also marked the beginning of technology-dependent operations for thoracic surgeons, and the necessarily close partnership between surgeons and industry. We are on an innovative technology superhighway and the pace of change is only going to be increasingly more rapid.

Quest for even less invasive surgical approaches takes two directions. First, there have been refinements of established VATS techniques which include the uniport approach and designs of miniaturized, procedure-specific instruments, as well as wireless visualization systems. Second, interests in natural orifice transluminal endoscopic surgery (NOTES) led to the development of endo-robotic arms, cross-discipline imaging assistance, and Electromagnetic Navigation Bronchoscopy (ENB) interventional platforms. On the anaesthesia side, it has been shown that thoracic surgery can be safely performed on sedated patients without intubation and mechanical ventilation. Thoracic surgery without an incision in an awake patient in an ambulatory setting will one day, no longer be a fantasy.

BIOGRAPHICAL

Yoshiya Toyoda, M.D., Ph.D.Vice Chief, Cardiovascular SurgerySurgical Director, Heart and Lung TransplantationDirector, Mechanical Circulatory SupportProfessor, Surgery 

Educational Background: Undergraduate degree, Kobe University, Kobe, Japan, 1986 MD, Kobe University School of Medicine, Kobe, Japan, 1990 Internship, Kobe University Hospital, Kobe, Japan, 1991 Residency, Kobe University Hospital, Kobe, Japan, 1994 Fellowship, Cardiac Surgery, Massachusetts General Hospital, Boston, MA Fellowship, Cardiopulmonary Transplant and Assist Device, University of Pittsburgh Medical Center Fellowship, Cardiac Surgery, Kobe Children's Hospital, Kobe, Japan 

 Clinical Interests: Surgical treatment for end-stage cardiopulmonary diseases including heart and lung transplantationMechanical circulatory support and artificial lungMajor cardiac surgery such as repair of aortic aneurysm and dissection, valve repair/replacementCoronary artery bypassAdult congenital heart surgery

 Board certification(s):  Thoracic and Cardiac SurgerySurgery

PROFESSIONAL AFFILIATIONS: American Association for Thoracic SurgerySociety of Thoracic SurgeonsInternational Society of Heart and Lung Transplantation

Research Interests:  Myocardial protection/preservationPulmonary protection/preservationCardiac artery function, Xenotransplantation

王 俊 主任醫師 教授 博士生導師 工作單位: 北京大學人民醫院胸外科，胸部微創中心，100044職稱：主任醫師，教授，博士研究生導師職務：北京大學人民醫院胸外科，主任　　　北京大學人民醫院胸部微創中心，主任　　　北京市海澱醫院胸外科，主任（兼）名譽職稱：廣東佛山市第一人民醫院，技術指導，客座教授 陝西省人民醫院，客座教授 河北醫科大學第一醫院，名譽教授專業特長：普通胸外科；胸部腫瘤；胸腔鏡外科；肺氣腫外科，縱隔鏡肺癌外科 重要成就： 創立了我國一個新學科- 中國電視胸腔鏡外科和胸部微創外科 建立了我國術前定量預測術後肺功能的核素檢查方法 在國際上首先證明DLco 與併發證、死亡率和長期生存率關係 開創了我國的肺氣腫外科學 在中國首先開展電視縱隔鏡手術

在中國積極倡導並首先開展肺癌外科規範化治療教育情況:1978-1980 河南省淮濱縣高級中學, 畢業1980-1985 河南醫科大學醫學系, 畢業 , 學士學位1985-1989 北京醫科大學研究生院, 畢業, 碩士學位1995.5-8 國際抗癌聯盟（UICC ），ICRETT Fellow1997-1998 美國胸外科學會(AATS) ，Graham Fellow工作情況:1985-1990 北京醫科大學第一醫院, 住院醫師和總住院醫師1990-1995 北京醫科大學第一醫院, 主治醫師1995-2000 北京醫科大學第一醫院, 副主任醫師1996-2000 北京醫科大學第一醫院, 副教授1999-2000 北京醫科大學第一醫院胸外科, 副主任2000-2002 北京大學人民醫院胸外科，主任醫師，教授，副主任2000- 目前 北京大學人民醫院胸部微創中心，主任醫師，教授，主任2001- 目前 北京大學人民醫院胸部微創中心，胸外科，博士生導師2002- 目前 北京大學人民醫院胸外科，胸部微創中心，主任2003- 目前 北京市海澱醫院胸外科，主任（兼）Autobiography

王俊教授1995年畢業于河南醫科大學並在北京醫科大學完成研究生學業，後由美國胸外科學會資助在美國8 所著名醫院胸外科訪問學習。現任教授、博士生導師、北京大學人民醫院胸外科主任、胸部微創中心主任、北京海澱醫院胸外科主任。王俊教授是我國胸部微創外科的開拓者，開拓了包括電視胸腔鏡、電視縱隔鏡、電視硬氣管食管鏡在國內的臨床應用，並已組織舉辦了九屆胸腔鏡手術學習班，培養了國內70% 的胸腔鏡外科醫師。除微創外科，王俊教授還建立了我國術前定量預測術後肺功能的核素檢查方法；在國際上首先證明DLco 與併發證、死亡率和長期生存率關係，並且在肺癌新輔助化療和分子水平胸部惡性腫瘤早期診斷方面進行了大量研究，完成國家及省部級課題6 項，發表論文100 余篇，主編專著5 部。

王俊教授曾獲國際抗癌聯盟，ICRETT Fellow 和美國胸外科學會，Graham Fellow 。現為中華胸心血管外科學會胸腔鏡外科學組組長、國際食管疾病學會(ISDE)亞洲主席、國際抗癌中華醫學會北京分會胸外科專業委員會常委、中華醫學會胸心血管外科學分會全國委員、中華全國青年聯合會第九屆委員會全國委員、亞太地區胸腔鏡外科學會執行委員、聯盟(UICC) 會員協會會員、美國胸外科學會(AATS) 執行會員、北京醫療事故鑒定委員會委員。王俊教授還擔任《中華胸心血管外科雜誌》編委，《中華外科雜誌》編委，《循證醫學》編委，《中國肺癌雜誌》常務編委，《中國微創外科雜誌》常務編委，《中國胸心血管外科臨床雜誌》編委，《食管外科》編委，《腹腔鏡外科雜誌》編委，《淮海醫藥》編委等。

CURRICULUM VITAE

Department of Gastrointestinal OncologyEsophageal Surgical DivisionNational Cancer Center Hospital EAST

NAMEHiroyuki DAIKO

PERSONAL DATAPlace of Birth; JapanCitizenship; Japanese

EDUCATION2007 Ph.D. Tokyo Woman’s Medical University1994 M.D. Tokai University School of Medicine

PERSONAL EXPERIENCE2013 Director of Esophageal Surgical Division

Department of Gastrointestinal OncologyEsophageal Surgical DivisionNational Cancer Center Hospital EAST

2004 Staff Surgeon of Esophageal Surgical DivisionDepartment of Gastrointestinal OncologyEsophageal Surgical DivisionNational Cancer Center Hospital EAST

2002 Research ResidentGenetics DivisionNational Cancer Center Hospital Research Institute

2001 Clinical Senior ResidentDepartment SurgeryEsophageal Surgical DivisionNational Cancer Center Hospital Central

1998 Clinical Junior ResidentDepartment SurgeryNational Cancer Center Hospital Central

1995 Clinical ResidentDepartment SurgerySeirei Hamamatsu General Hospital

1994 Clinical ResidentDepartment Surgery IITokyo Woman’s Medical University

CURRICULUM VITAE

Name: Liu, Hui-Ping 劉 會 平

Employment Record: May 1987 ~ June 1990 R1~ R3, Dept of Surgery, Chang Gung Memorial Hospital, TaipeiJuly 1990 ~ June 1992 Fellow, Dept of Thoracic & Cardiovascular Surgery, CGMH, TaipeiJuly 1992 ~ July 2009 Attending Staff, Dept of Thoracic & Cardiovascular Surgery, CGMHAug 1993 ~ July 2000 Lecturer of Thoracic & Cardiovascular Surgery, Chang Gung UniversityJuly 1997 ~ June 2003 Associate Professor of Thoracic & Cardiovascular Surgery,

Chang Gung Memorial HospitalJuly 1999 ~ June 2006 Chief, Division of Thoracic Surgery,

Chang Gung Memorial Hospital, Linkou Medical CenterAug 2000 ~ July 2005 Associate Professor of Surgery, Chang Gung UniversityJuly 2003 ~ July 2009 Professor of Thoracic & Cardiovascular Surgery,

Chang Gung Memorial HospitalAug 2005 ~ July 2009 Professor of Surgery, Chang Gung UniversityAug 2006 ~ July 2009 Vice-superintendent

Chang Gung Memorial Hospital, KeelungJuly 2009 ~ 2011 Superintendent, BenQ Hospital, Nanjing, ChinaNov 2011 ~ Superintendent, New Journey Hospital, Beijing, China

Professional Affiliations: 1. Formosan Medical Association2. The Surgical Association of the Republic of China (1991)3. Taiwan Society of Cardiology (1992)4. Association of Thoracic & Cardiovascular Surgery, Republic of China (1992)5. Surgical Society of Gastroenterology, Republic of China (1992)6. International Society of Cardiothoracic Surgeons (ISCTS)(1993)7. Taiwan Society of Pulmonary and Critical Care Medicine (1993)8. Chinese Association for Endoscopic Surgery (1993)9. Collegium Internationale Chirurgiae Digestivae (CICD)(1993)10. American College of Chest Physicians (FCCP) (1993)11. Endoscopic and Laparoscopic Surgeons of Asia (ELSA) (1994)12. World Association for Bronchology (1994)13. American Association for Bronchology (1994)14. European Association for Endoscopic Surgery (EAES) (1994)15. International Society for Disease of the Esophagus (ISDE)(1997)16. Society of Thoracic Surgery (STS) USA (1998)17. American College of Surgery (FACS) (1998)18. Asian Pacific Society of Respirology (APSR) (1998)

19. Asian Society for Cardiovascular Surgery (1998)20. International Association for the Study of Lung Cancer (IASLC) (1999)21. The International Pediatric Endosurgery Group (IPEG)(1999)

Research Interest: 1. Minimal access thoracic surgery2. Lung Transplantation3. Thoracoscopic Surgery (Video-assisted thoracic surgery)4. Esophageal Surgery5. Traditional Chinese Medicine (CAM)

Dae Joon Kim, MD

1. Affiliation

- Assistant professor, Department of Thoracic & Cardiovascular Surgery, Yonsei University College of Medicine,

Seoul, Korea

- Head, Lung Cancer Center, Yonsei Cancer Hospital, Seoul, Korea

- Vice director, Emergency Center, Severance hospital, Seoul, Korea

2. Education & Training

- Graduated Yonsei University College of Medicine in 1993

- Completed cardiothoracic residency at Severance hospital in 1998

- Completed master in medical science in 2004

3. Professional appointment

- 2002 / 2003 : clinical fellow, Severance hospital

- 2004 / 2005 : Instructor, Department of Thoracic & Cardiovascular Surgery, Yonsei University

- 2008 / 2010 : Professor of Surgery, King Saud University, Riyadh, Kingdom of Saudi Arabia

4. Academic activities

- Head, Educational committee, Korean Association of Thoracic Surgical Oncology

- Executive director, Korea Association of Broncho-esophagology

- Member, Educational committee, Korean Association of Thoracic & Cardiovascular Surgery

- Member, International relations committee, Korean Association of Study for Lung Cancer

5. Main interests

- Robot-assisted thoracoscopic surgery for esophageal cancer

- Lymph node navigation using the robotic system

- Management of multiple GGOs in lung cancer

- VATS segmentectomy

CURRICULUM VITAE

EDUCATION PhD. 1996-2001 Graduate Institute of Clinical Medicine, National Taiwan University, Taipei, Taiwan, ROCM.D. 1982-1989College of Medicine, National Taiwan University, Taipei, Taiwan, ROCTEACHING EXPERIENCE Professor 2014-presentClinical professor 2012-2013Clinical associate professor 2006-2011College of Medicine, National Taiwan University, Taipei, Taiwan, ROCClinical assistant professor 2002-2005College of Medicine, National Taiwan University, Taipei, Taiwan, ROC

PROFESSIONAL EXPERIENCE Chief, Division of Thoracic Surgery 2011-present Dept. of Surgery, National Taiwan University Hospital, Taipei, Taiwan, ROCVisiting Staff 1996-present Dept. of Surgery, National Taiwan University Hospital, Taipei, Taiwan, ROCResearch Fellow 1999-2000Dept. of Surgery, Beth Israel, Deaconess Medical Center Harvard Medical School, Boston MA, USAResident 1991-1996 Dept. of Surgery, National Taiwan University Hospital, Taipei, Taiwan, ROCSecretary GeneralTaiwan Association of Thoracic ＆ Cardiovascular Surgery 2014-presentAsia Thoracoscopic Surgery Education Program 2014-presentCommittee memberTaiwan Association of Thoracic ＆ Cardiovascular Surgery 2006-present Association of International Chinese Thoracic 2007-present ＆Cardiovascular SurgeryAsia Thoracoscopic Surgery Education Program 2014-present Reviewer International Journal of Cancer 2001-present Taiwan Surgical Association 2001-present Formosan Medical Association 2003-present

Jang-Ming Lee, MD., PhD.

Dept. of Surgery, National Taiwan University HospitalNo.7, Chung Shan S. Rd., Taipei 100, Taiwan, ROC

Cancer Letters 2005-present Carcinogenesis 2006-present Asian Journal of Surgery 2010-present EditorAsian Journal of Surgery 2014-presentAmerican Journal of cancer review  2013-presentHindawi Journals   2014-presentTranslational Cancer Research 2011-present

HONORS AND AWARDS Best Research Paper-Type B, National Science Council, Taiwan, ROC (2000) Scientific Abstract Award, 12th World Congress of the International Society for Diseases of the Esophagus,

Kagoshima, Japan (2010) Best Teaching Award of attending physicians in NTUH, NTUMC North American Alumni Foundation (2014)

PATENT US 6,639,122 B1 (2003-2020)Title: Transgenic swine having HLA-D gene, swine cells thereof and xenografts there from

US 20110091871 A1 (2009~2029)Title: Biomarkers for predicting response of esophageal cancer patient to chemoradiotherapy

Curriculum VitaeName: Chih-Cheng HsiehCurrent title: Attending Surgeon of Thoracic SurgeryDivision of Thoracic Surgery, Department of Surgery, Taipei-Veterans General Hospital

Education:1985-1992 School of Medicine, National Yang-Ming University, Taipei, MD degree2005-2007 Institute of Hospital and Health Case Administration, National Yang-Ming University, Taipei, Master degree2009-Present Institute of Clinical Medicine, National Yang-Ming University, Taipei

Professional career:1990-1992 Taipei-Veterans General Hospital Taipei, Internship1992-1994 Nan-Tze Veterans Hospital, Kaohsiung, Resident1994-1998 Taipei-Veterans General Hospital Taipei, Resident1998-1999 Taipei-Veterans General Hospital Taipei, Chief Resident1999-2000 Taipei-Veterans General Hospital Taipei, Clinical Fellow2000-2011 National Yang-Ming University, Taipei, Taiwan, Lecturer of Surgery2001-Present Taipei-Veterans General Hospital Taipei, Attending Surgeon2003-2004 Southern California University, Los Angeles, CA, USA, Research Fellow2008-2011 Secretary in General, Taiwan Association of Thoracic and Cardiovascular Surgery2011-Present National Yang-Ming University, Taipei, Taiwan, Assistant Professor

Board Certification and Membership:1992 Doctor of Medicine, Department of Health, Taiwan1998 Board of General Surgery, Department of Health, Taiwan1999 Board of Taiwan Association of Thoracic and Cardiovascular Surgery1999 Board of Taiwan Society of Pulmonary and Critical Care Medicine2000 Board of Taiwan Surgical Society of Gastroenterology2000 Board of Taiwan Association for Surgery of Trauma2000 Board of Taiwan Association for Endoscopic Surgery2008 Member of The Society for Surgery of the Alimentary Tract (SSAT)

Curriculum Vitae

Name YingChieh Su, 蘇英傑Current position

Attending physician, Department of thoracic surgery, Chimei medical center財團法人奇美醫學中心胸腔外科主治醫師Attending physician, Department of medical education, Chimei medical center財團法人奇美醫學中心教學主治醫師Consultant, HIWIN technology corp.上銀科技研發顧問

Academic interests

Esophageal cancerLung cancerVideothoracoscopic surgery (VATS, MIS, MIE)da Vinci robotic surgery (RATS, RAMIE)Medical robot developmentHepatic(Renal) hydrothoraxMedical photonic system

Education Department of medicine, Kaohsiung medical university, Kaohsiung, Taiwan高 雄 醫 學 大 學 醫 學 系 畢 業

1996-2003, MD

Department of photonic system, National Chiao Tung university, Tainan, Taiwan交 通 大 學 光 電 系 統 研 究 所 博 士 班 就 學 中

2012-now, PhD

Medical training

Resident and chief resident, department of thoracic surgery, Chimei medical center, Tainan, Taiwan

2003-2008

Mayo clinic visiting staff 2011/8-2012/1

Memorial Sloan-Kettering cancer center (MSKCC) visiting staff

2012/1-2012/2

Medical certification

Surgeon specialist, R.O.C.中 華 民 國 外 科 醫 學 會 專 科 醫 師Pulmonary and Cardiovascular Surgeon specialist, R.O.C.中 華 民 國 胸 腔 暨 心 臟 血 管 外 科 醫 學 會 專 科 醫 師Trauma specialist, R.O.C.台 灣 外 傷 醫 學 會 專 科 醫 師Surgical intensive care specialist, R.O.C.台 灣 外 科 醫 學 會 外 科 重 症 加 護 專 科 醫 師

教 學 資 歷奇美醫學中心臨床教師

台灣醫學教育學會一般醫學師資奇美醫學中心教學主治醫師

教 學 榮 譽奇美醫院99年度優良教師第二名奇美醫院100 年度優良教師第三名奇美醫院101 年度傑出教師奇美醫院103 年度跨職類教學特殊貢獻獎

CURRICULUM VITAE Name: Hsieh, Ming-Ju 謝明儒Education:

1986~1990 Medical College, National Taiwan University, Taipei, Taiwan, R.O.C.1990~1995 Kaohsiung Medical College, Kaohsiung, Taiwan, R.O.C.

Employment Record: July 1994~June 1995 Internship, Chang Gung Memorial Hospital

Aug 1995~July 1998 R1, R2 & R3, Div of General Surgery, Chang Gung Memorial HospitalAug 1998~July 2000 Fellow, Div of Thoracic & Cardiovascular Surgery, CGMHAug 2000~ Attending Staff, Div of Thoracic Surgery, CGMHDec 2002~Aug 2004 Chief, Div of Thoracic Surgery, CGMH at ChaiYiJuly 2009~ Assistant Professor, Div of Thoracic & Cardiovascular Surgery, CGMHAug 2010~ Assistant Professor of Surgery, Chang Gung University

Feb. 2011~ Physician Educator, Chang Gung Memorial HospitalProfessional Affiliations:

1. Taiwan Surgical Association (1999)2. Taiwan Association of Thoracic & Cardiovascular Surgery3. Taiwan Society of Pulmonary and Critical Care Medicine4. Chinese Association for Endoscopic Surgery5. Taiwan Lung Cancer Society6. American College of Chest Physicians (FCCP)7. The International Association for the Study of Lung Cancer(IASLC)8. Taiwan Association of Medical Education

Research Interest: Cardiovascular and Thoracic Surgery, Medical Education

Curriculum Vitae

Name: Cheng-Yen Chuang, MD.Current Title: Attending Surgeon of Thoracic SurgeryHobbies and Interests:

Bicycle Badminton

Address: Office: Division of Thoracic Surgery, Surgical department, Taichung Veterans

General Hospital#1650, Sect.4, Taiwan Boulevard, Taichung, Taiwan

Education and Training: 1985-1992 Taipei Medical College, MD. Degree 1992-1994 Military Service 1994-1998 Taichung Veterans General Hospital, Resident 1998-1999 Taichung Veterans General Hospital, Chief Resident 2012 Chung-Shan Medical University, MD. PhD Degree

Career to Date: 1999-2004 Attending Surgeon of Thoracic Surgery (Taichung Veterans General Hospital) 2004-2007 Chief of Thoracic Surgery (Chung-Hwa Show Chwan Memorial Hospital) 2007-present Attending Surgeon of Thoracic Surgery (Taichung Veterans General Hospital)

Memberships of Associations and Institutes: 1998, Board of General Surgery, Taiwan 1999, Board of Taiwan Society of Pulmonary and Critical Care Medicine 1999, Borad of Association of Thoracic and Cardiovascular Surgery 2000, Board of Digestive Endoscopic Society of Taiwan 2004, Board of Taiwan Society of Critical Care Medicine

Diego Gonzalez Rivas, M.D, FETCSCoruña University HospitalXubia 84Coruña  15008SpainRole: Surgeon

Subspecialty(ies)

General Thoracic Surgery

Background

Dr. Diego Gonzalez Rivas is a graduate of Santiago de Compostela University and the College of Physicians & Surgeons of Coruña University (MD). He received training in General Surgery, Thoracic Surgery, and lung transplantation at Coruña University Hospital.

After completing a year working in Santiago University Hospital he joined the faculty at Coruña Hospital and is currently Thoracic Surgeon in Coruña University center and an active member of lung transplantation program. He is the head of minimally invasive thoracic surgery Unit working at Coruña hospital, USP institution, San Rafael hospital and Modelo medical center.

Dr Gonzalez Rivas serves on several editorial boards and is active member organizing the annual meeting of Spanish society of thoracic surgery (SECT) and collaborate with educational activities of European Society (ESTS). He is a board European certified surgeon since 2010 (FECTS). He is specially dedicated to minimally invasive thoracic surgery (VATS). He was pioneer surgeon in the world performing uniportal VATS lobectomies and he has published several papers describing this procedure and the results in the most important medical journals. 

Interests

Uniportal VATS lobectomyMinimally invasive thoracic surgerySingle-port VATS sleeve resectionAdvanced lung cancer surgeryRobotic surgeryLung TransplantationVideo editionSurfing

Curriculum VitaeNAME: Jin-Shing Chen, M.D. PhD

CURRENT APPOINTMENT:

Professor, Department of Surgery, National Taiwan University School of MedicineDirector, Department of Traumatology, National Taiwan University HospitalChief, Division of Experimental Surgery, National Taiwan University HospitalAttending Surgeon, Division of Thoracic Surgery, National Taiwan University Hospital

 EDUCATION:

1986-1993 M.D., National Taiwan University, Taiwan.

1999-2004 PhD of Institute of Clinical MedicineNational Taiwan University, School of Medicine  

POSTDOCTORAL TRAINING1994-1999 Residency

National Taiwan University Hospital, Taipei, TaiwanResident in Surgery, 1994-1997Chief Resident in Surgery, 1997-1998

1999-2000 Research followDivision of Thoracic Surgery, Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan

 2002-2003 Visiting scientistDepartment of Molecular and Cellular Oncology, MD Anderson Cancer Center, University of Texas, TX, USA

EMPLOYMENT:  

 2000-present Attending SurgeonDivision of Thoracic Surgery, Department of Surgery National Taiwan University Hospital

2001-2004 

2004-2009

2009-2013

Instructor, Department of Surgery, National Taiwan University School of Medicine Assistant Professor of Surgery, National Taiwan University School of MedicineAssociate Professor, Department of Surgery, National Taiwan University School of Medicine

2009-2011 Chief, Department of Surgery, National Taiwan University Hospital

2009-2011Yun-Lin Branch Chief, Center of Oncology, National Taiwan University Hospital Yun-Lin Branch

2012-present- Deputy Editor in Chief, Journal of Thoracic Disease (SCIE)Editor, Journal of Formosan Medical Association (SCI)Editor, Scientific reports (SCI)

Membership Taiwan Surgical Association, memberTaiwan Association of Thoracic and Cardiovascular Surgery, memberTaiwan Society of Pulmonary and Critical Care Medicine, member

Awards and Honor 2006: Best Attending Physician, National Taiwan University Hospital2007: Best Teaching Award, National Taiwan University Hospital2008: Best Clinical Teacher, National Taiwan University Hospital2009: Certification of Symbol of National Quality, Center of Oncology, NTUH Yin-Lin Branch2009: Teaching award, National Taiwan university 2010: Teaching award, National Taiwan university2011: Teaching award, National Taiwan university2012: Excellent Research Award, National Taiwan university Hospital2013: Excellent Research Award, National Taiwan university Hospital2014: Teaching award, National Taiwan university

Areas of Research Interest:1. Non-intubated thoracoscopic surgery2. Innovative treatment for lung cancer3. Treatment for primary spontaneous pneumothorax4. Clinical trials for lung cancer and pneumothorax

Liu Chia-Chuan, M.D

Specialty: Minimally invasive thoracic surgery for lung and esophageal cancer ← School : China Medical University 1992

Residency: Taipei Veterans General Hospital

Fellowship: Thoracic Surgery, Taipei Veterans General Hospital

Observer in Duke University Hospital 2007/7-2007/9

OFFICE: Koo Foundation Sun Yat-Sen Cancer Center.125 Lih-Der Road, Pei-Tou District, Taipei, Taiwan. (Zip code 11259)

-Biography Dr. Chia-Chuan Liu graduated from China Medical University in 1992, and completed his residency and fellowship

training in the Veteran General Hospital-Taipei in 2000. He now heads the thoracic surgery division in SYSCC, and has chaired the minimally invasive committee since 2008.

His clinical interest is multimodality and minimally invasive surgery for lung and esophageal cancer. He initiated the VATS forum in Taiwan early in 2005, doing live demonstration surgery for VATS lobectomy and minimally invasive esophagectomy for both Taiwan and foreign chest surgeons, collaborated with other leaders to set up animal lab worshop in Taiwan, and he is also now engaged in establishing the “Taiwan Esophageal Cancer Study Group” based on a nation-wide database -Taiwan Cancer Registry.

Membership in Professional Societies

Member, Taiwan Joint Cancer Association

Member, Taiwan Surgical Association

Member, Taiwan Society of Thoracic & Cardiovascular Surgery

Member, Taiwan Society of Pulmonary and Critical Care Medicine

Member, Taiwan Surgical Society of Gastroenterology

Member, The Society of Ultrasound in Medicine, R.O.C.

Academic Appointment

Lecturer, Department of Surgery, National Defense Medical Center

Clinical Assistant Professor of Surgery, National Yang-Ming University College of Medicine Clinical Interests:

Thoracic minimally invasive surgery (Video Assisted Thoracic Surgery)

Single port surgery for primary lung cancer

Minimally invaive surgery for esophageal cancer and cancer of gastric cardia

Surgery for mediastinal tumor

Fellowship training program for thoracic minimally invasive surgery

1.

Research Interests:

Clinical research for lung cancer

Clinical research for esophageal cancer

Affiliations/ Certifications:

1999 Board of Surgery

1999 Board of Thoracic Surgery

1999 Board of Pulmonary and Critical Care Medicine

Academic / professional Titles:

Chair of Minimally Invasive Surgery Committee

Vice leader of Lung and Esophageal Cancer Functional Group, SYSCC.

Member of Intensive Care Unit Committee, SYSCC

Curriculum Vitae 一、 個人背景姓名：林洧呈 Wei-Cheng Lin

二、 學、經歷臺北市立萬芳醫院 胸腔外科 代主任/ 主治醫師 2012年09月- 迄今新光醫院 胸腔外科 兼任主治醫師 2012年11月- 迄今新光醫院 胸腔外科 主治醫師 2007年07月-2012 年08

月新光醫院 外傷科 兼任主治醫師 2010年02月-2012 年08

月臺大醫院 胸腔外科 總住院醫師 2005年07月-2007 年06

月臺大醫院 外科部 住院醫師 2002年07月-2005 年06

月國立台灣大學 電機資訊學院 生醫電子與資訊學

研究所博士班2008年09月- 迄今

國立台灣大學 醫學院 醫學系 1994年09月-2001 年06月

三、 相關證書醫師證書外科專科醫師證書台灣胸腔及心臟血管外科醫學會專科醫師證書台灣胸腔暨重症專科醫師證書台灣外科重症加護專科醫師證書四、研究成果目錄

2007Wei-Cheng Lin a , Yung-Chie Lee a , Jin-Shing Chen a , Wen-Je Ko a , Shuenn-Wen Kuo a , Hsao-Hsun Hsu a . Add-on sildenafil therapy for chronic thromboembolic pulmonary hypertension. Respiratory Medicine Extra.Volume 3, Issue 3, 2007, 130–133

2007Lin WC, Tseng YT, Chang YL, Lee YC. Pulmonary tumour with high carcinoembryonic antigen titre caused by chronic propolis aspiration. Eur Respir J. 2007 Dec;30(6):1227-30.

2008

Intramuscular Lipoma Arising in the Intercostal Muscle-A Case Report肋間肌肉肌內脂肪瘤－病例報告林洧呈 (Wei-Cheng Lin) ; 張逸良(Yih-Leong Chang); 李元麒(Yung-Chie Lee)胸腔醫學Thoracic Medicine Vol.23 No.1 (2008/02) 31-35

CURRICULUM VITAE

Name: Chen, Tzu-Ping 陳 子 平 Education:

1989~1996 China Medical College, Taichung, Taiwan

Employment Record: July 1998 ~ June 2001 R1~ R3, Dept of Surgery, Chang Gung Memorial Hospital, TaipeiJuly 2001 ~ June 2003 Fellowship, Div of Thoracic & Cardiovascular Surgery, CGMH, TaipeiJuly 2003 ~ Sep 2003 Attending physician, Div of Thoracic & Cardiovascular Surgery, CGMH, TaipeiOct 2003 ~ June 2004 Attending physician, Div of Thoracic & Cardiovascular Surgery, CGMH, JyayiJuly 2004 ~ Attending physician, Div of Thoracic & Cardiovascular Surgery, CGMH, Keelung

Research Interest: 1. Minimal access thoracic surgery2. Thoracoscopic Surgery (Video-assisted thoracic surgery)3. Mininvasive Esophageal Surgery

CURRICULUM 　VITAE

PERSONAL INFORMATION Name : Hironari ShiwakuPresent Affliliation : Department of Gastroenterological Surgery, Fukuoka University, Faculty of Medicine, Nanakuma 7-45-1, Jonan-ku, Fukuoka, 814-0180, Japan

WORK EXPERIENCE 2003-

Resident, Department of Gastroenterological Surgery, Fukuoka University, Faculty of Medicine, Fukuoka, Japan

2004- Resident, Department of Surgery, Kitakyushu Municipal medical center, Fukuoka, Japan

2005-Surgical stuff, Yamamoto Memorial Hospital, Saga, Japan

2006-Senior Resident, Kitakyushu Municipal medical center, Fukuoka, Japan

2007-Research Associate, Department of Gastroenterological Surgery, Fukuoka University, Faculty of Medicine, Fukuoka, Japan

2008-2009Assistant Professor, Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan

2010-Research Associate, Department of Gastroenterological Surgery, Fukuoka University, Faculty of Medicine, Fukuoka, Japan

EDUCATION AND DEGREEMarch 2003

Graduated from Fukuoka university, School of medicineFukuoka, Japan

April 2003Success in the National Examination for Medical Practitioner( The registration number: 436717) Awarded the degree of Medical Sciences (M.D.)

MEMBERSHIP Japan Surgical Society

Board Certified SurgeonJapan Gastroenterological Endoscopy Society

Board Certified Member, CouncilorCouncilor

Japanese gastrointestinal associationBoard Certified Member

American Society for Gastrointestinal Endoscopy (ASGE) 　International membership

PRIZE ✤Ito Prize of Japan society for endoscopic surgery (2011) 　

‘Clinical experience of full thickness resection of early gastric cancer with severe scar : CLEAN-NET (Combination of Laparoscopic and Endoscopic Approaches to Neoplasia with Non Exposure Technique)’

1✤ st.prize of International Symposium on Complications in GI Endoscopy (Hannover, 2009)

‘Cases of perforation during and after ESD procedure’

Pinghong ZHOU, MD, PhD

Dr. Pinghong Zhou is currently a specialist in therapeutic endoscopy, as well as a general surgeon of Zhongshan Hospital, Fudan University, Shanghai, China.

Dr. Zhou graduated from Shanghai Medical University in 1992, and obtained his doctorate degree (Doctor of Surgery) from Fudan University in 2003. Having completed his basic surgical training in the department of general surgery of Zhongshan Hospital from 1992 to 1998, he started his training in digestive endoscopy as a senior resident in 1999. He also received the most comprehensive training in various areas of advanced endoscopy, such as EUS under the mentorship of Kenjiro Yasuda in Kyoto Second Red Cross Hospital of Japan in 2000, ESD under Hiroyuki Ono in Shizuoka Cancer Center of Japan in 2006, ERCP under Peter B Cotton in the Medical University of South Carolina, USA in 2008.

His main medical work focuses on endoscopic diagnosis and treatment of gastrointestinal tumor. He is one of ESD pioneers in China and has gained much experience in EMR, EPMR and ESD. Recently he is very interested in endoscopic resection of submucosal tumor (SMT) and tunnel endoscopic surgery, such as submucosal tunnel endoscopic resection (STER), peroral endoscopic myotomy (POEM) of esophageal achalasia.

He has already edited 3 books on ESD and endoscopic resection and published over 100 papers in Chinese journals and 50 papers in international peer-reviewed journals such as Endoscopy, Gastrointestinal Endoscopy and Surgical Endoscopy. Also he has chaired 1st to 7th Sino-Japan Summit Forum on ESD and more than 30 ESD and POEM training courses in China, giving presentations and live demonstration in more than 30 countries.

上海市肺科医院 汪浩主任医师 工作经历90年复旦大学医学院毕业后即在上海市肺科医院胸外科工作至今1997年10月-12 月在日本大阪府羽曳野病院研修2008年获得苏州大学硕士学位2008年内窥镜室主任，主持医院内窥镜室工作曾获得上海市科技进步奖二等奖2 次，教育部科技进步奖二等奖1 次，中华科技进步奖二等奖1 次主要学术任职任上海市医学会中西医胸外科分会委员

CURRICULUM VITAE Name: Weisheng Chen Office Address: Cardiothoracic Surgery Department

Fuzhou General Hospital, Fuzhou, ChinaEducation: 2004-2006 ------- Fujian Medical University, PhD1996-1999 ------- The First Military Medical University, Master of Surgery1991-1996 ------- The First Military Medical University, Medical Bachelor, MD

Professional Experience:

1999 – 2000 Intern and Junior Resident in General Surgery Fuzhou General Hospital (a Teaching Affiliate Hospital of Fujian Medical University)

2000 – 2001 Senior and Chief Resident in General SurgeryFuzhou General Hospital

2001 – 2002 Critical Care Medicine FellowshipFuzhou General Hospital

2002 – 2004 Clinical Fellowship Cardiothoracic SurgeryFuzhou General Hospital

2003 – 2006 Resident and Chief Resident in Cardiothoracic SurgeryFuzhou General Hospital

2006 – 2007 Clinical Fellowship VATSMinimally Invasive Surgery Center, GuanzhouMedical School of Guanzhou Affiliated Hospitals

2008–2009 Clinical research fellowDepartment of Surgery, Keck Medical School, USC

2009-pres Assistant Professor of Thoracic Surgery. Department of General Thoracic Surgery, Fuzhou General Hospital

Research/Funding Information:

2004-2006 Computer-Aided Surgery and VATS Supported by the Natural Science Foundation of Fujian Province of China

2006-Present Simplified implantation procedure of the stentless aorticvalve (sutureless xenografts aortic valves) Supported by the Natural Science Foundation of FujianProvince of China

Board Certification And Licensure:Chinese Surgeon, 2002Chinese Society of Cardiac and Thoracic Surgeons 2005

CURRICULUM VITAE

Name: Liu, Yun-Hen 劉永恆Office Address: Thoracic & Cardiovascular Surgery, Chang Gung Memorial Hospital

5, Fu-Hsing Street, Kuei-Shan Hsiang, Taoyuan Hsien, Taiwan 333

Education:

1986~1993 Taipei Medical College, Taipei, Taiwan

Employment Record:

Jul 1994 ~ Jun 1997 R1~R3, Dept of Surgery, Chang Gung Memorial Hospital

Jul 1997 ~ Jun 1999 Fellow, Div of Thoracic & Cardiovascular Surgery, CGMH

Jul 1999 till now Attending Staff, Section of Thoracic Surgery, CGMH

Sep 2000 ~ May 2001 Clinical Fellow, Division of Cardiothoracic Surgery, University of Washington, Seattle, Washington, USA

May 2001~ June 2001 Clinical Fellow, Division of General Thoracic Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA

Jun 2001~ Aug 2001 Clinical Fellow, Department of Cardiothoracic Surgery, Washington University School of Medicine, Barnes-Jewish Hospital, St. Louis, USA

Jul 2004 ~ Jun 2010 Assistant Professor, Div of Thoracic & Cardiovascular Surgery, CGMH

Aug 2005 ~ Jul 2011 Assistant Professor of Surgery, Chang Gung University

Jul 2010 ~ present Associate Professor, Div of Thoracic & Cardiovascular Surgery, CGMH

Aug 2011 ~ 2014 Associate Professor of Surgery, Chang Gung University

Aug 2014 ~ present Professor of Surgery, Chang Gung Memorial Hospital

Board Certification:

1. The Surgical Association of the Republic of China

2. Association of Thoracic & Cardiovascular Surgery, Republic of China

3. Chinese Association for Endoscopic Surgery

4. Taiwan Society for Vascular Surgery

Professional Affiliations:

1. Formosan Medical Association

2. The Surgical Association of the Republic of China

3. Association of Thoracic & Cardiovascular Surgery, Republic of China

4. Taiwan Society of Pulmonary Critical Care Medicine

5. Chinese Association for Endoscopic Surgery

6. American College of Chest Physician

7. Taiwan Lung Cancer Society

8. Taiwan Society for Vascular Surgery

Research Interest: 1. Natural orifice transluminal endoscopic surgery2. Tracheal surgery (http://www.vascular.idv.tw/chest/)3. Thoracoscopic Surgery (Video-assisted thoracic surgery)4. Lung Transplantation

Honors and Awards:

Invited as Editorial Board & Guest Reviewer :1. Chest2. European journal of cardiothoracic surgery3. Asian Cardiovascular & Thoracic Annals4. Respirology5. Journal of the Formosan Medical Association

Curriculum vitae

Sanghoon Jheon, M.D., Ph.D. ( 錢 相 勳)

Current position; Professor and Chairman,

Department of Thoracic and Cardiovascular SurgerySeoul National University College of Medicine, Seoul, Korea.

Chief Financial & Strategy Officer,Seoul National University Bundang Hospital, Korea.

Visiting Professor,Department of Surgery,Tokyo Medical University, Tokyo, Japan

Education and affiliation1984, Graduate @ Kyungpook National University School of Medicine, Korea

1994, Ph.D.1984-1989 Residency in Thoracic and Cardiovascular Surgery

at Kyungpook National University Hospital, Korea1990-1993 Medical officer at Korean Army1993-1994 Chief of Thoracic Surgery, Andong General Hospital1994-2000 Instructor, Assistant professor, Associate professor

at Kyungpook National University, Korea2001-2002 Director of Faculty of Medicine

at Catholic University of Daegu, Korea2003-present Professor

at Seoul National University, Korea

1994 visiting surgeon at National Cancer Center, Japan1997-1998 fellowship at MGH, Boston, MA, USA

Academic interests; Thoracic surgical oncology, Thoracoscopic surgery,Clinical trials, Cardiopulmonary physiology, microimaging,Tissue engineering, Lung cancer screening and smoking cessation

Medical Society Activity;Member, Academy of Medicine of KoreaPresident, Asia Thoracoscopic Surgery Education Program(ATEP)Chairman, Korea-Japan Thoracoscopic Surgery SummitFounding Chairman, Korean Study Group of Thoracoscopic Surgery

Board member, Korean Association for Thoracic and Cardiovascular SurgeryBoard member, Korean Association of BronchoesophagologyBoard member, Korean Association of Photodynamic TherapyBoard member, Asian Thoracic Surgical ClubMember, International Association for the Study of Lung CancerMember, International Society of Heart and Lung Transplantation …

CURRICULUM VITAE

Name: Chao, Yin-Kai 趙盈凱 1994~2001 MD; Chang Gung University, Taoyuan, Taiwan

Post-Graduate Education:2006/9~2011/8 PHD; Graduate Institute of Clinical Medical Sciences, Change Gung University, Taoyuan, Taiwan

Employment Record:

July 2000~June 2001 Internship, Chang Gung Memorial Hospital Aug 2001~Aug 2004 R1, R2 & R3, Div of General Surgery, Chang Gung Memorial Hospital

Aug 2004~Aug 2006 Fellow, Div of Thoracic & Cardiovascular Surgery, Chang Gung Memorial Hospital July 15~31, 2006 Fellow, Div of Thoracic Surgery, National Cancer Center, Tokyo, Japan

Aug 2006~ Attending Staff, Div of Thoracic & Cardiovascular Surgery, Chang Gung Memorial Hospital

July 2008~June 2011 Lecturer, Div of Thoracic & Cardiovascular Surgery, CGMHAug 2009~ Lecturer of Surgery, Chang Gung UniversityJuly 2011~ Assistant professor, Div of Thoracic & Cardiovascular Surgery, CGMH

Board Certification: 1. Taiwan Surgical Association2. Taiwan Association of Thoracic & Cardiovascular Surgery.3. Taiwan Society of Pulmonary and Critical Care Medicine4. Taiwan Society of Critical Care Medicine5. Taiwan Society for Vascular Surgery

Professional Affiliations:1. Taiwan Surgical Association2. Taiwan Association of Thoracic & Cardiovascular Surgery3. Taiwan Society of Pulmonary and Critical Care Medicine4. Taiwan Society of Critical Care Medicine5. Taiwan Society for Vascular Surgery

Research Interest: 1. Cardiovascular and Thoracic Surgery2. Thoracic Oncology (Esophageal cancer)

CURRICULUM VITAEName : ANTHONY PING-CHUEN YIM

Title: Private Practice Honorary Clinical Professor

Institution / Organization:

Minimally Invasive Thoracic Surgery Centre

The Chinese University of Hong Kong

Qualifications:

Bachelor of Arts (Cambridge) with Double First Class Honours

(Medical Science Tripos, Part II in Pathology)

1981

Bachelors of Medicine and Surgery (Oxford) 1984

Master of Arts (Cambridge) 1985

Master of Arts (Oxford) 1985

Diploma of the American Board of Surgery 1992

Cardiothoracic Surgery Board (The College of Surgeons of Hong Kong) 1994

Specialist Registration (Cardiothoracic Surgery)(Medical Council of Hong Kong Ref. No. S31-0010)

1997

Fellow of the Royal College of Surgeons of Glasgow FRCS by election 1997

Fellow of the Royal College of Surgeons of England ad eundem 1998

Fellow of the Royal College of Surgeons of Edinburgh (without examination) 1998

Doctor of Medicine (Oxford) 1999

Membership / Fellowship of Learned Societies:

1. American Association for Thoracic Surgery (AATS)

2. The Society of Thoracic Surgeons

3. General Thoracic Surgery Club

4. American College of Chest Physicians (FCCP)

5. American College of Surgeons (FACS)

6. The American Thoracic Society

7. European Association for Cardio-Thoracic Surgery (EACTS)

8. American Heart Association

9. Hong Kong Academy of Medicine (FHKAM)

10. The New York Academy of Sciences

11. The College of Surgeons of Hong Kong (FCSHK)

12. The International College of Surgeons

13. The University of Chicago Surgical Society (Life member)

14. The Society of Laparoendoscopic Surgeons

15. Hong Kong Surgical Laser Association

16. International Association for Cardiac Biological Implants

17. International Society of Cardiothoracic Surgeons (ISCTS)

18. Pan-Pacific Surgical Association

19. American Association For The Advancement of Science (AAAS)

20. The Endoscopic and Laparoscopic Surgeons of Asia (ELSA)

21. Chinese Medical Association-Subspecialty Membership in Cardiothoracic Surgery

1. Fellow of the International Biographical Association (FIBA)

Awards and Distinctions at University and Medical School:

At Cambridge

Queens' College Exhibition 1980

Queens' College Prize 1980

Mosseri Prize for Distinction in Physiology 1980

Queens' College Foundation Scholarship 1981

Queens' College Prize 1981

Melsome Memorial Prize for the Most Outstanding Graduate in Natural Sciences 1981

Dr. A.M. Barrett Memorial Prize for Research in Pathology 1981

At Oxford

Hobson Memorial Entrance Scholarship to the Clinical School 1981

Brian Johnson Prize in Pathology 1982

Green College Scholarship 1982

W.T. Lee Travel Scholarship to Hong Kong 1984